Advanced BioPhotonics to study use of infrared imaging technology in plastic surgery

By Angela McDaniels

Seattle, June 1 - Advanced BioPhotonics Inc. said it has recruited Hospital of The University of Pennsylvania - Department of Surgery to participate in the company's multi-center clinical trial investigating the use of Advanced BioPhotonics' proprietary DIRI method of dynamic infrared imaging in mapping vascular perforator blood vessels in plastic and reconstructive surgery procedures.

Hospital of The University of Pennsylvania is the second medical center to join the multi-center trial. The company expects two additional medical institutions to join the trial in the next several weeks and expects to conclude the trial in September.

Advanced BioPhotonics is conducting the trial as a follow-up to an earlier study done at the University of Geneva, Switzerland, the results of which showed "great promise" for the use of DIRI dynamic infrared imaging in the localization of perforator blood vessels in flap procedures, according to a company news release.

"This study represents an important surgical application that promises to shorten [operating room] procedure times by providing surgeons with anatomical information and measurements not readily available with alternative imaging techniques," Advanced BioPhotonics senior vice president Robert Ellis said in the release.

To conduct this study, which is scheduled to begin within two weeks, the Hospital of The University of Pennsylvania will use Advanced BioPhotonics' patented BioScanIR System, a functional medical imaging modality that provides a fast, non-invasive, radiation-free method for detecting diseases that affect perfusion and reperfusion in human tissue, the company said.

"This new technology will allow us to make faster intra-operative decisions, reducing operative time while making our reconstructions more reliable," Joseph M. Serletti, chief of plastic surgery at Hospital of The University of Pennsylvania, said in the release.

"This new imaging will also allow us to continue to limit the donor site dissection leading to faster and fuller recoveries for our patients."

Advanced BioPhotonics is a medical imaging technology company based in Bohemia, N.Y.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.